Lucideon's new in vitro cell biology lab brings a new level of biological capabilities to its materials science toolbox, advancing support for pharmaceutical and biotech product development.
Cell biology is the study of cells, their structure, behaviour, and function in response to stimuli. Understanding these processes is crucial for the development of materials and chemicals intended for contact with humans such as medical devices or pharmaceuticals.
Lucideon is excited to announce the launch of its new in vitro cell biology laboratory, further enhancing its materials consulting and commercialization capabilities. This new facility allows Lucideon to deliver essential cell biology testing in-house, offering clients comprehensive support for pharmaceutical and biotechnology product development and process improvement.
Recognising the growing demand for healthcare-related offerings, Lucideon identified the need to integrate cell biology expertise alongside its established strengths in chemical and physical materials testing. Establishing this capability has been made possible through a successful partnership with the School of Engineering and Materials Science (SEMS) at Queen Mary University of London (QMUL).
Through a Knowledge Transfer Partnership (KTP), partially funded by the UK Government, Lucideon hosted a highly experienced post-doctoral researcher for 30 months on-site with the aim of transferring advanced cell biology expertise to the Lucideon team. This collaboration builds on a long-standing relationship with SEMS, which has previously supported Lucideon's projects in developing healthcare and implant materials.
The cell biology lab offers a range of services, including cytotoxicity testing, with plans to expand the service offering into more advanced solutions based on client needs and exciting novel cell tests. These services are designed to accelerate product development across medical devices, pharmaceuticals, consumer healthcare products, and novel materials.
February 2025